Walmart settles US government's opioid lawsuit
Walmart has reached a settlement with the U.S. government over allegations that the retailer unlawfully dispensed opioid prescriptions from its pharmacies, according to the Department of Justice. The lawsuit, filed by the DOJ in 2020, accused Walmart of violating the federal Controlled Substances Act since 2013, potentially exposing the company to billions in civil penalties.
A spokesperson for the Department of Justice stated that the settlement resolves allegations concerning the company's pharmacies' non-compliance with Controlled Substances Act obligations in dispensing opioids and other controlled substances. Walmart expressed satisfaction with the resolution, reaffirming its commitment to supporting its pharmacists in providing outstanding patient care.
In March 2024, U.S. District Judge Colm Connolly dismissed certain claims, allowing the government to pursue a claim that pharmacists dispensed prescriptions Walmart compliance personnel knew were invalid.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Walmart settles DOJ opioid crisis lawsuit for $50 million thehill.com
- Walmart settles U.S. government's opioid lawsuit cnbc.com
- Walmart settled the U.S. government's long-running opioid lawsuit over its pharmacies qz.com
- Walmart settles opioid lawsuit brought by Justice Department cbsnews.com
- Walmart settles US government’s opioid lawsuit aljazeera.com
- Walmart settles federal government opioids lawsuit seekingalpha.com
- Walmart settles US government’s opioid lawsuit, Justice Department says investing.com
